BRIEF-IAVI Spokesperson Expects Ebola Vaccine Candidate Doses To Be Ready For Evaluation In Humans By 2026 End

June 24 (Reuters) - IAVI Spokesperson:

  • IAVI SCIENTISTS ARE PREPARING THE EBOLA VACCINE CANDIDATE FOR GMP PRODUCTION AT OUR LABORATORY IN NEW JERSEY- SPOKESPERSON

  • ANTICIPATE DOSES OF EBOLA VACCINE CANDIDATE WILL BE READY FOR EVALUATION IN HUMANS BY THE END OF 2026- IAVI SPOKESPERSON


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.